{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:46:57Z","timestamp":1792007217203,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20755-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:43:35Z","timestamp":1761039815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhancing the solubility of celecoxib via lyophilized solid dispersions using computational and experimental approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Fatima","family":"Rasool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20755_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","volume":"57","author":"P Augustijns","year":"2014","unstructured":"Augustijns, P. et al. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. Eur. J. Pharm. Sci. 57, 322\u2013332 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"20755_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejps.2007.05.110","volume":"31","author":"S Stegemann","year":"2007","unstructured":"Stegemann, S., Leveiller, F., Franchi, D., de Jong, H. & Lind\u00e9n, H. When poor solubility becomes an issue: from early stage to proof of concept. Eur. J. Pharm. Sci. 31(5), 249\u2013261 (2007).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"20755_CR3","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/jps.22405","volume":"100","author":"GA Stephenson","year":"2011","unstructured":"Stephenson, G. A., Aburub, A. & Woods, T. A. Physical stability of salts of weak bases in the solid-state. J. Pharm. Sci. 100(5), 1607\u20131617 (2011).","journal-title":"J. Pharm. Sci."},{"key":"20755_CR4","doi-asserted-by":"publisher","first-page":"139562","DOI":"10.1016\/j.ijbiomac.2025.139562","volume":"295","author":"P Gong","year":"2025","unstructured":"Gong, P. et al. Effect of ultrasound synergistic pH shift modification treatment on Hericium erinaceus protein structure and its application in 3D printing. Int. J. Biol. Macromol. 295, 139562 (2025).","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"20755_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijpharm.2012.08.042","volume":"453","author":"Y Lu","year":"2013","unstructured":"Lu, Y. & Park, K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm. 453(1), 198\u2013214 (2013).","journal-title":"Int. J. Pharm."},{"issue":"3","key":"20755_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cbpa.2009.04.620","volume":"13","author":"B Testa","year":"2009","unstructured":"Testa, B. Prodrugs: bridging pharmacodynamic\/pharmacokinetic gaps. Curr. Opin. Chem. Biol. 13(3), 338\u2013344 (2009).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"11","key":"20755_CR7","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s11095-008-9676-2","volume":"25","author":"K Shiraki","year":"2008","unstructured":"Shiraki, K., Takata, N., Takano, R., Hayashi, Y. & Terada, K. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm. Res. 25(11), 2581\u20132592 (2008).","journal-title":"Pharm. Res."},{"issue":"4","key":"20755_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jsps.2013.05.004","volume":"22","author":"KR Vandana","year":"2014","unstructured":"Vandana, K. R., Prasanna Raju, Y., Harini Chowdary, V., Sushma, M. & Vijay Kumar, N. An overview on in situ micronization technique \u2013 An emerging novel concept in advanced drug delivery. Saudi Pharm. J. 22(4), 283\u2013289 (2014).","journal-title":"Saudi Pharm. J."},{"key":"20755_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jddst.2015.05.009","volume":"30","author":"M Rodriguez-Aller","year":"2015","unstructured":"Rodriguez-Aller, M., Guillarme, D., Veuthey, J-L. & Gurny, R. Strategies for formulating and delivering poorly water-soluble drugs. J. Drug Deliv. Sci. Technol. 30, 342\u2013351 (2015).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"20755_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jsps.2013.12.013","volume":"23","author":"BB Patel","year":"2015","unstructured":"Patel, B. B., Patel, J. K., Chakraborty, S. & Shukla, D. Revealing facts behind spray dried solid dispersion technology used for solubility enhancement. Saudi Pharm. J. 23(4), 352\u2013365 (2015).","journal-title":"Saudi Pharm. J."},{"key":"20755_CR11","doi-asserted-by":"crossref","unstructured":"Vo, C. L. N., Park, C. & Lee, B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharmaceutics. 85(3, Part B), 799\u2013813 (2013).","DOI":"10.1016\/j.ejpb.2013.09.007"},{"issue":"16","key":"20755_CR12","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2165\/00003495-200767160-00008","volume":"67","author":"JE Frampton","year":"2007","unstructured":"Frampton, J. E. & Keating, G. M. Celecoxib. Drugs. 67(16), 2433\u20132474 (2007).","journal-title":"Celecoxib Drugs"},{"issue":"3","key":"20755_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00003088-200038030-00003","volume":"38","author":"NM Davies","year":"2000","unstructured":"Davies, N. M., McLachlan, A. J., Day, R. O. & Williams, K. M. Clinical pharmacokinetics and pharmacodynamics of celecoxib. Clin. Pharmacokinet. 38(3), 225\u2013242 (2000).","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"20755_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/v10007-007-0014-8","volume":"57","author":"V Gupta","year":"2007","unstructured":"Gupta, V., Mutalik, S., Patel, M. & Jani, G. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties. Acta Pharm. 57(2), 173\u2013184 (2007).","journal-title":"Acta Pharm."},{"issue":"5","key":"20755_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40005-015-0192-1","volume":"45","author":"S Chakma","year":"2015","unstructured":"Chakma, S. et al. Solubility enhancement of celecoxib using solidified tween 80 for the formulation of tablet dosage forms. J. Pharm. Invest. 45(5), 449\u2013460 (2015).","journal-title":"J. Pharm. Invest."},{"key":"20755_CR16","doi-asserted-by":"crossref","unstructured":"Kim, H-I. et al. Development and evaluation of a reconstitutable dry suspension to improve the dissolution and oral absorption of poorly water-soluble celecoxib. Pharmaceutics. 10(3). (2018).","DOI":"10.3390\/pharmaceutics10030140"},{"key":"20755_CR17","doi-asserted-by":"crossref","unstructured":"Ding, Z. et al. Enhanced oral bioavailability of celecoxib nanocrystalline solid dispersion based on wet media milling technique: formulation, optimization and in vitro\/in vivo evaluation. Pharmaceutics. 11(7) (2019).","DOI":"10.3390\/pharmaceutics11070328"},{"key":"20755_CR18","doi-asserted-by":"crossref","unstructured":"Arslan, A. et al. Celecoxib nanoformulations with enhanced solubility, dissolution Rate, and oral bioavailability: experimental approaches over in Vitro\/In vivo evaluation. Pharmaceutics. 15(2) (2023).","DOI":"10.3390\/pharmaceutics15020363"},{"issue":"1","key":"20755_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12247-022-09641-1","volume":"18","author":"NM Nazem","year":"2023","unstructured":"Nazem, N. M. et al. Combining liquisolid and co-grinding techniques to enhance the dissolution rate of celecoxib. J. Pharm. Innov. 18(1), 300\u2013309 (2023).","journal-title":"J. Pharm. Innov."},{"issue":"3","key":"20755_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40005-013-0067-2","volume":"43","author":"JH Lee","year":"2013","unstructured":"Lee, J. H. et al. Enhanced dissolution rate of celecoxib using PVP and\/or HPMC-based solid dispersions prepared by spray drying method. J. Pharm. Invest. 43(3), 205\u2013213 (2013).","journal-title":"J. Pharm. Invest."},{"key":"20755_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijpharm.2019.04.051","volume":"564","author":"JB Ahn","year":"2019","unstructured":"Ahn, J. B., Kim, D-H., Lee, S-E., Pyo, Y-C. & Park, J-S. Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. Int. J. Pharm. 564, 263\u2013272 (2019).","journal-title":"Int. J. Pharm."},{"issue":"1","key":"20755_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1208\/s12249-010-9560-3","volume":"12","author":"X He","year":"2011","unstructured":"He, X., Pei, L., Tong, H. H. Y. & Zheng, Y. Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with pluronic F68 to improve dissolution and oral bioavailability. AAPS PharmSciTech. 12(1), 104\u2013113 (2011).","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"20755_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1211\/jpp.59.5.0004","volume":"59","author":"D Douroumis","year":"2007","unstructured":"Douroumis, D., Bouropoulos, N. & Fahr, A. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. J. Pharm. Pharmacol. 59(5), 645\u2013653 (2007).","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"20755_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jcs.2004.03.004","volume":"40","author":"IS Chronakis","year":"2004","unstructured":"Chronakis, I. S., \u00d6ste Triantafyllou, A. & \u00d6ste, R. Solid-state characteristics and redispersible properties of powders formed by spray-drying and freeze-drying cereal dispersions of varying (1\u21923,1\u21924)-\u03b2-glucan content. J. Cereal Sci. 40(2), 183\u2013193 (2004).","journal-title":"J. Cereal Sci."},{"issue":"5","key":"20755_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1023\/A:1023450006281","volume":"20","author":"G Verreck","year":"2003","unstructured":"Verreck, G., Chun, I., Peeters, J., Rosenblatt, J. & Brewster, M. E. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res. 20(5), 810\u2013817 (2003).","journal-title":"Pharm. Res."},{"issue":"6","key":"20755_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11095-018-2408-3","volume":"35","author":"X Lin","year":"2018","unstructured":"Lin, X. et al. Physical stability of amorphous solid dispersions: a physicochemical perspective with thermodynamic, kinetic and environmental aspects. Pharm. Res. 35(6), 125 (2018).","journal-title":"Pharm. Res."},{"issue":"3","key":"20755_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/acs.molpharmaceut.5b00655","volume":"13","author":"D Prasad","year":"2016","unstructured":"Prasad, D., Chauhan, H. & Atef, E. Role of molecular interactions for synergistic precipitation Inhibition of poorly soluble drug in supersaturated drug\u2013polymer\u2013polymer ternary solution. Mol. Pharm. 13(3), 756\u2013765 (2016).","journal-title":"Mol. Pharm."},{"key":"20755_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejps.2015.05.018","volume":"77","author":"F Meng","year":"2015","unstructured":"Meng, F., Dave, V. & Chauhan, H. Qualitative and quantitative methods to determine miscibility in amorphous drug\u2013polymer systems. Eur. J. Pharm. Sci. 77, 106\u2013111 (2015).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"20755_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.polymer.2003.11.021","volume":"45","author":"H Yang","year":"2004","unstructured":"Yang, H., Ze-Sheng, L., Qian, H., Yang, Y., Zhang, X. & Sun, C-C. Molecular dynamics simulation studies of binary blend miscibility of poly(3-hydroxybutyrate) and poly(ethylene oxide). Polymer 45(2), 453\u2013457 (2004).","journal-title":"Polymer"},{"issue":"5","key":"20755_CR30","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1021\/mp500068w","volume":"11","author":"PK Jha","year":"2014","unstructured":"Jha, P. K. & Larson, R. G. Assessing the efficiency of polymeric excipients by atomistic molecular dynamics simulations. Mol. Pharm. 11(5), 1676\u20131686 (2014).","journal-title":"Mol. Pharm."},{"issue":"6","key":"20755_CR31","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11095-023-03517-w","volume":"40","author":"SR Munnangi","year":"2023","unstructured":"Munnangi, S. R. et al. Drug complexes: perspective from academic research and pharmaceutical market. Pharm. Res. 40(6), 1519\u20131540 (2023).","journal-title":"Pharm. Res."},{"key":"20755_CR32","doi-asserted-by":"crossref","unstructured":"Munnangi, S. R. et al. Continuous manufacturing of solvent-free cyclodextrin inclusion complexes for enhanced drug solubility via hot-melt extrusion: A quality by design approach. Pharmaceutics. 15(9) (2023).","DOI":"10.3390\/pharmaceutics15092203"},{"key":"20755_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.carbpol.2015.08.012","volume":"134","author":"N Devasari","year":"2015","unstructured":"Devasari, N. et al. Inclusion complex of erlotinib with sulfobutyl ether-\u03b2-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Carbohydr. Polym. 134, 547\u2013556 (2015).","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"20755_CR34","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1021\/acs.cgd.2c01285","volume":"23","author":"M Wang","year":"2023","unstructured":"Wang, M., Ran, Q., Wu, S., Han, D. & Gong, J. Study on the role of polymers in preventing the crystallization of roxadustat in an aqueous environment. Cryst. Growth. Des. 23(3), 1718\u20131725 (2023).","journal-title":"Cryst. Growth. Des."},{"issue":"44","key":"20755_CR35","doi-asserted-by":"publisher","first-page":"12698","DOI":"10.1021\/acs.iecr.7b03187","volume":"56","author":"Y Yani","year":"2017","unstructured":"Yani, Y., Kanaujia, P., Chow, P. S. & Tan, R. B. H. Effect of API-Polymer miscibility and interaction on the stabilization of amorphous solid dispersion: A molecular simulation study. Ind. Eng. Chem. Res. 56(44), 12698\u201312707 (2017).","journal-title":"Ind. Eng. Chem. Res."},{"key":"20755_CR36","doi-asserted-by":"crossref","unstructured":"Shah, S. N. H. et al. Permeation kinetics studies of physical mixtures of artemisinin in polyvinylpyrrolidone. Dissol Technol. (2012).","DOI":"10.14227\/DT190412P6"},{"issue":"3","key":"20755_CR37","first-page":"108","volume":"13","author":"A Suryawanshi","year":"2025","unstructured":"Suryawanshi, A. et al. A review on solid dispersion and polymers used for solubility enhancement through lyophilization technique. Asian J. Pharm. Res. Dev. 13(3), 108\u2013113 (2025).","journal-title":"Asian J. Pharm. Res. Dev."},{"issue":"2","key":"20755_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1081\/DDC-200047795","volume":"31","author":"MS Nagarsenker","year":"2005","unstructured":"Nagarsenker, M. S. & Joshi, M. S. Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage. Drug Dev. Ind. Pharm. 31(2), 169\u2013178 (2005).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"20755_CR39","doi-asserted-by":"crossref","unstructured":"Dezani, A. B., Pereira, T. M., Caffaro, A. M., Reis, J. M. & Serra, C. H. R. Equilibrium solubility versus intrinsic dissolution: characterization of lamivudine, stavudine and Zidovudine for BCS classification. Braz. J. Pharm. Sci. 49(2013).","DOI":"10.1590\/S1984-82502013000400026"},{"issue":"11","key":"20755_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/17435889.2025.2501518","volume":"20","author":"R Liaqat","year":"2025","unstructured":"Liaqat, R. et al. Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method. Nanomedicine 20(11), 1235\u20131247 (2025).","journal-title":"Nanomedicine"},{"key":"20755_CR41","doi-asserted-by":"crossref","unstructured":"Verma, M. et al. Development, optimization, and evaluation of solid lipid nanoparticles of celecoxib. Nanosci. Nanotechnol. (2024).","DOI":"10.2174\/0122106812334601241023113656"},{"issue":"1","key":"20755_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejpb.2007.01.014","volume":"67","author":"PN Davies","year":"2007","unstructured":"Davies, P. N., Worthington, H. E. C., Podczeck, F. & Newton, J. M. The determination of the mechanical strength of tablets of different shapes. Eur. J. Pharm. Biopharm. 67(1), 268\u2013276 (2007).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"20755_CR43","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1021\/acs.cgd.4c00277","volume":"24","author":"D Biri","year":"2024","unstructured":"Biri, D., Jaeggi, A., Malach, P., Rajagopalan, A. K. & Mazzotti, M. Multistage crystallization of plate-like crystals: A modeling and experimental study on adipic acid. Cryst. Growth. Des. 24(10), 4170\u20134182 (2024).","journal-title":"Cryst. Growth. Des."},{"issue":"5","key":"20755_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11095-018-2374-9","volume":"35","author":"E Hadjittofis","year":"2018","unstructured":"Hadjittofis, E. et al. Influences of crystal anisotropy in pharmaceutical process development. Pharm. Res. 35(5), 100 (2018).","journal-title":"Pharm. Res."},{"issue":"3","key":"20755_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1021\/mp900304p","volume":"7","author":"K Pajula","year":"2010","unstructured":"Pajula, K., Taskinen, M., Lehto, V-P., Ketolainen, J. & Korhonen, O. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory\u2009\u2013\u2009Huggins interaction parameter and phase diagram. Mol. Pharm. 7(3), 795\u2013804 (2010).","journal-title":"Mol. Pharm."},{"key":"20755_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jddst.2016.06.005","volume":"35","author":"M Kimura","year":"2016","unstructured":"Kimura, M. & Ooya, T. Enhanced solubilization of \u03b1-tocopherol by hyperbranched polyglycerol-modified \u03b2-cyclodextin. J. Drug Deliv. Sci. Technol. 35, 30\u201333 (2016).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"20755_CR47","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.cjche.2020.03.040","volume":"28","author":"A Mohammadi","year":"2020","unstructured":"Mohammadi, A. & Moghaddas, J. Mesoporous tablet-shaped potato starch aerogels for loading and release of the poorly water-soluble drug celecoxib. Chin. J. Chem. Eng. 28(7), 1778\u20131787 (2020).","journal-title":"Chin. J. Chem. Eng."},{"issue":"1","key":"20755_CR48","first-page":"180845","volume":"2014","author":"H Kaur","year":"2014","unstructured":"Kaur, H. & Kaur, G. A critical appraisal of solubility enhancement techniques of polyphenols. J. Pharm. 2014(1), 180845 (2014).","journal-title":"J. Pharm."},{"key":"20755_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpb.2021.04.009","volume":"164","author":"PHL Tran","year":"2021","unstructured":"Tran, P. H. L., Lee, B-J. & Tran, T. T. D. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion. Eur. J. Pharm. Biopharm. 164, 13\u201319 (2021).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"20755_CR50","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/17425247.2011.598147","volume":"8","author":"P Srinarong","year":"2011","unstructured":"Srinarong, P., de Waard, H., Frijlink, H. W. & Hinrichs, W. L. J. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin. Drug Deliv. 8(9), 1121\u20131140 (2011).","journal-title":"Expert Opin. Drug Deliv."},{"issue":"4","key":"20755_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14227\/DT160409P22","volume":"16","author":"VM Pandya","year":"2009","unstructured":"Pandya, V. M., Patel, D. J., Patel, J. K. & Patel, R. P. Formulation, characterization, and optimization of fast-dissolve tablets containing celecoxib solid dispersion. Dissolution Technol. 16(4), 22\u201327 (2009).","journal-title":"Dissolution Technol."},{"issue":"1","key":"20755_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tca.2005.09.011","volume":"439","author":"D Bikiaris","year":"2005","unstructured":"Bikiaris, D. et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim. Acta. 439(1), 58\u201367 (2005).","journal-title":"Thermochim. Acta"},{"key":"20755_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-443-13466-1.00030-1","volume-title":"Specification of Drug Substances and Products (Third Edition)","author":"EB Sheinin","year":"2025","unstructured":"Sheinin, E. B. Chapter 7 - Pharmacopeial methods and tests. In Specification of Drug Substances and Products (Third Edition) (eds Riley, C. M. & Nguyen, K. L.) 161\u2013184. (Elsevier, 2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20755-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:02:08Z","timestamp":1761429728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20755-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20755"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20755-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36782"}}